Primary and secondary intralymphatic histiocytosis - 16/04/14
, Naomi Webber, MRCP a, Hiva Fassihi, MA, MD, MRCP a, Victoria Swale, MRCP b, Fiona Lewis, MRCP a, Ed Rytina, FRCPath c, Galia Tamar Ben-Zvi, MRCP d, Paul Norris, MA, FRCP d, Olivia Espinosa, FRCPath, DipRCPath e, Sunanda Dhar, FRCPath e, Paul Craig, FRCPath, DipRCPath, FRCPA f, Alistair Robson, FRCPath, DipRCPath aAbstract |
Background |
Intralymphatic histiocytosis (IH) is a rare condition often associated with systemic disease. A benign condition, clinical presentations can vary greatly and its cause is largely unknown. Histologically, there are macrophages within distended lymphatic vessels, although this can be an incidental finding or the primary abnormality.
Objective |
We present a series of 7 cases of IH with and without disease associations, and a review of the literature. We propose IH as either primary (without associated conditions) or secondary (associated with systemic disease).
Methods |
This was a retrospective collection of patients whose skin biopsy specimens revealed intralymphatic collections of histiocytes. We reviewed their clinical presentation, disease associations, and staining of slides with CD68 in all cases, D2-40 in 5 cases, and HLA-DR in 4 cases.
Results |
Clinical features were highly variable, and not all cases were associated with systemic disease. One case had admixed reactive angioendotheliomatosis. All 4 cases stained for HLA-DR showed strong expression by the intralymphatic macrophages.
Limitations |
Retrospective analysis and limited numbers are limitations.
Conclusion |
IH is not always associated with systemic disease although macrophage activation nevertheless implies immune activation.
Le texte complet de cet article est disponible en PDF.Key words : CD68, Crohn's disease, D2-40, HLA-DR, intralymphatic histiocytosis, intralymphatic macrophages, rheumatoid arthritis
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 70 - N° 5
P. 927-933 - mai 2014 Retour au numéro
Article précédent
- Basal cell carcinomas of the ear are more aggressive than on other head and neck locations
- Patrick M. Mulvaney, H. William Higgins, Raymond G. Dufresne, Antonio P. Cruz, Kachiu C. Lee
- Elastophagocytosis: Underlying mechanisms and associated cutaneous entities
- Jinane El-Khoury, Mazen Kurban, Ossama Abbas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?